Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 6.60
+0.15 (2.33%)
At close: Dec 3, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 124.52 million as of December 5, 2025. Its market cap has increased by 119.06% in one year.
Market Cap
124.52M
Enterprise Value
101.34M
Revenue
17.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.60
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 124.52M, an increase of 7.73%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 124.52M | 79.84% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | 115.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 987.21B |
| Atlas Copco AB | 791.55B |
| AB Volvo | 603.21B |
| ASSA ABLOY AB | 400.88B |
| EQT AB | 386.41B |
| Skandinaviska Enskilda Banken AB | 372.94B |
| Sandvik AB | 365.53B |
| Swedbank AB | 340.75B |